Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF – Get Free Report)’s share price hit a new 52-week low during mid-day trading on Friday . The stock traded as low as $19.9825 and last traded at $19.9825, with a volume of 1717 shares traded. The stock had previously closed at $20.48.
Hikma Pharmaceuticals Stock Performance
The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.72 and a current ratio of 1.24. The firm’s 50 day moving average is $21.82 and its 200 day moving average is $24.24.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals is a multinational pharmaceutical company that develops, manufactures and markets a broad range of branded and non-branded generics, specialty injectables and consumer healthcare products. The company’s three core business segments include generic medicines, injectable products and branded generics, serving hospitals, wholesalers and pharmacies worldwide. Its product portfolio spans diverse therapeutic areas such as cardiovascular, oncology, respiratory, pain management and anti-infectives, with an emphasis on injectable solutions for complex hospital treatments.
Founded in 1978 in Amman, Jordan, Hikma has grown through organic expansion and strategic acquisitions to become one of the leading pharmaceutical players in the Middle East, North Africa, Europe and the United States.
Featured Articles
- Five stocks we like better than Hikma Pharmaceuticals
- Investing In Automotive Stocks
- These 3 Banks Are Rallying Into Year-End, But Will It Continue?
- ESG Stocks, What Investors Should Know
- 3 Surging Stocks Just Got the Ultimate Stamp of Approval From the S&P 500
- Stock Sentiment Analysis: How it Works
- This ETF Caught a Major Tailwind After the Fed’s Rate Cut
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
